Authors


Christina G. Rivera, PharmD, BCPS

Latest:

ID Consultation Associated With Reductions in ED Visits, Hospital Admissions, and Cost for OPAT Patients

This In the Literature piece details a study evaluating the effects of ID consultation for OPAT patients.


KAITE KAMMERS, PHARMD, BCPS

Latest:

Exploring Primary Prophylaxis for Invasive Pulmonary Aspergillosis

Invasive aspergillosis affects up to 13% of immunocompromised patients who are in the hospital.


YASIR AL-KHALILI, MD

Latest:

Searching for the Cause of Hearing Loss in a Patient With HIV

Early diagnosis and treatment were essential to ensuring a good prognosis.


Joseph DeRose, DO

Latest:

Doravirine: Researchers DRIVE for a Drug Ahead of Its Class

A novel NNRTI hits the market, but what place will it have in treatment?


Amanda Warren

Latest:

Aging HIV-Infected Population Faces Unique Challenges

As the population of people living with HIV infection is living longer, age-related health issues are affecting these individuals in an accelerated or emphasized fashion.


Glenn S. Tillotson, PhD, FIDSA, FCCP

Latest:

Reviewing Real-World Cases of C diff Biotherapeutic

Here is a brief report of 5 cases of the use of fecal microbiota, live-jslm (Rebyota) in the management of recurrent Clostridioides difficile infection.



MICHAEL P. VEVE, PHARMD

Latest:

Considerations for Aerosolized Antibiotics in Multidrug-Resistant Gram-Negative Pneumonia

Aerosolized antibiotics are a reasonable adjunctive option to treat multidrug-resistant gram-negative pneumonia due to excellent pulmonary concentrations and few adverse effects.


Anita Ko, MD

Latest:

Final Diagnosis: Disseminated Kaposi Sarcoma With Tonsillar and Pulmonary Involvement

A shocking find on a CT scan leads to an unexpected diagnosis.


AMY FORRESTEL, MD

Latest:

Never Ignore a New Rash in a Patient With AIDS

A case of Kaposi sarcoma with immune reconstitution inflammatory syndrome.


Yoav Golan, MD

Latest:

ABSSSI and OPAT: Key Messages

Panelists hypothesize on theoretical downsides of resistance development for gram-negative infections and reflect on the importance of implementing outpatient parenteral antibiotic therapy.



Milena McLaughlin, PharmD, MSC, BCPS-AQ ID, AAHIVP

Latest:

Undetectable Equals Untransmittable

A breakthrough message for patients that must be delivered correctly by health care providers. The Undetectable Equals Untransmittable, or U=U, move­ment is a global campaign definitively stating that people living with HIV (PLWH) who have undetectable HIV RNA are unable to transmit HIV. By educating people, the hope is that they will get tested and, if necessary, start and stay on treatment. This message has been endorsed by many organizations, including the US Centers for Disease Control and Prevention and the HIV Medicine Association.




Evan Loh, MD, Chief Executive Officer, Paratek Pharmaceuticals

Latest:

Antibiotic Resistance: Challenges and Opportunities for Treating Serious Bacterial Skin Infections

As current antibiotics become less effective due to bacterial resistance, there is high demand for new and effective therapies with both IV and oral formulations.



RAVINDRA SANGITHA, MD

Latest:

Salt, Ticks, and Lyme: A Case of Lyme Neuroborreliosis Presenting as SIADH

This case report is the fourth documented case of Lyme-induced syndrome of inappro­priate secretion of antidiuretic hormone (SIADH).


Christian Sandrock, MD, MPH, FCCP

Latest:

Key Takeaways on Managing Antimicrobial Resistant Gram-Negative Infections

Christian Sandrock, MD, MPH, FCCP, shares key takeaways on the antimicrobial resistant gram-negative infection space from ID week 2023.



Liza Vaezi, MSc, Pharm D, BCPS-AQID

Latest:

Carriage of ESBL-PE May Increase the Risk of Colorectal Surgical Site Infections

Is it time to screen for these bacteria and modify colorectal surgical prophylaxis?



William R. Short, MD, MPH

Latest:

An Unusual Case of Testicular Swelling in a Patient With HIV

Being immunocompromised increases risk of rare Mycobacterium tuberculosis epididymo-orchitis.


Jennifer Barrett

Latest:

Can Drinking Coffee Boost Survival Rates Among HIV/HCV Co-Infected Patients?

The results of a 5-year study show that coffee drinking can cut down the risk of all-cause mortality in patients with HIV and hepatitis C virus (HCV) infections.


Contagion&r Editorial Staff

Latest:

Border Patrol Stance on Flu Vaccines Mobilizes ID Community

Three children in US Customs and Border Protection custody have died since December 2018, partially due to influenza. Now, the infectious disease community is rallying for vaccination for migrants in detention facilities.



M. Hong Nguyen, MD

Latest:

Bringing Culture-Independent Diagnostic Tests for Bloodstream Infections Into Rational Patient Management

These tests have the potential to transform patient care and antimicrobial stewardship, but they have not gained widespread acceptance, partly because of uncertainty over how to use them clinically.



Lauren Santye

Latest:

Influenza Triggers Immune Responses Resulting in Relapse in Patients with Multiple Sclerosis

A recent study investigates what causes relapse in those with multiple sclerosis and sought to glean insight into the brain activity of patients with MS during respiratory infections.


Krista Rossi

Latest:

Controversies in C Difficile Prevention

Nicola Petrosillo, MD, discusses current controversies in C difficile prevention and treatment.

© 2024 MJH Life Sciences

All rights reserved.